整合适应疗法对马来西亚缅甸难民常见心理健康症状与适应压力的随机对照试验
该单盲随机对照试验纳入331名居住在吉隆坡的缅甸钦族、克钦族和罗兴亚难民,比较整合适应疗法(IAT)与认知行为疗法(CBT)各6周每周45分钟 session 的疗效。意向性分析显示,治疗后6周IAT在PTSD、复杂PTSD、抑郁症所有常见精神障碍症状及多数适应压力指数维度上优于CBT,且韧性评分提高,但组间差异 modest。
要点
- IAT在改善PTSD、CPTSD、MDD症状及适应压力(除不公正维度)上优于CBT。
- IAT组韧性评分提高幅度大于CBT组,效应量差异 modest。
- 两种疗法均未记录不良事件,但随访时间短且可能存在偏倚。
核心结论
- 与CBT相比,IAT在治疗后6周对常见精神障碍症状和适应压力的改善更优,但组间差异 modest,需独立团队验证。
研究设计与样本
- 单盲随机对照试验,2017年10月至2019年5月在马来西亚吉隆坡开展,纳入钦族(39.3%)、克钦族(15.7%)和罗兴亚族(45%)难民。
- IAT组170人,CBT组161人,均接受每周1次45分钟、共6次的治疗;IAT组失访4人(保留97.6%),CBT组失访5人(保留96.8%)。
- 参与者平均年龄30.8岁(SD=9.6),平均经历或目睹10.1种(SD=5.9,范围1-27)创伤事件。
主要发现
- 意向性分析(n=331)显示,治疗后6周IAT组在PTSD、CPTSD、MDD症状及ASI-1(安全/保障)、ASI-2(创伤性丧失)、ASI-4(角色/身份中断)、ASI-5(存在意义)维度上较CBT组改善更显著。
- 调整后平均治疗效应(以基线评分为协变量):PTSD -0.08(95%CI: -0.14至-0.02,p=0.012),CPTSD -0.07(95%CI: -0.14至-0.01),MDD -0.07(95%CI: -0.13至-0.01,p=0.025),CDRS 0.16(95%CI: 0.06-0.026,p≤0.001),ASI-1 -0.12(95%CI: -0.20至-0.03,p≤0.001),ASI-2 -0.10(95%CI: -0.18至-0.02,p=0.02),ASI-3 -0.03(95%CI: -0.11至0.06,p=0.513),ASI-4 -0.12(95%CI: -0.21至-0.04,p≤0.001),ASI-5 -0.18(95%CI: -0.19至-0.05,p≤0.001)。
- IAT组效应量:PTSD d=0.93,CPTSD d=1.27,MDD d=1.4,ASI-1 d=1.1,ASI-2 d=0.81,ASI-3 d=0.49,ASI-4 d=0.86,ASI-5 d=0.72;CBT组相应效应量分别为0.87、1.02、1.11、0.85、0.66、0.42、0.67、0.53。
- 两种疗法均未记录不良事件。
临床怎么用
- 对于经历多重创伤的难民群体,IAT可作为改善常见精神障碍症状和适应压力的候选心理干预。
- 临床选择时需注意IAT与CBT的组间差异 modest,且证据受限于短期随访和潜在偏倚。
局限性
- 可能存在效忠效应(作者在培训和督导中无意间对IAT表现出过度热情)。
- 可能存在交叉效应(咨询师在实施一种疗法时应用了另一种疗法的元素)。
- 随访时间短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This randomised controlled trial (RCT) aims to compare 6-week posttreatment outcomes of an Integrative Adapt Therapy (IAT) to a Cognitive Behavioural Therapy (CBT) on common mental health symptoms and adaptive capacity amongst refugees from Myanmar. IAT is grounded on psychotherapeutic elements specific to the refugee experience. METHODS AND FINDINGS: We conducted a single-blind RCT (October 2017 -May 2019) with Chin (39.3%), Kachin (15.7%), and Rohingya (45%) refugees living in Kuala Lumpur, Malaysia. The trial included 170 participants receiving six 45-minute weekly sessions of IAT (97.6% retention, 4 lost to follow-up) and 161 receiving a multicomponent CBT also involving six 45-minute weekly sessions (96.8% retention, 5 lost to follow-up). Participants (mean age: 30.8 years, SD = 9.6) had experienced and/or witnessed an average 10.1 types (SD = 5.9, range = 1-27) of traumatic events. We applied a single-blind design in which independent assessors of pre- and posttreatment indices were masked in relation to participants' treatment allocation status. Primary outcomes were symptom scores of Post Traumatic Stress Disorder (PTSD), Complex PTSD (CPTSD), Major Depressive Disorder (MDD), the 5 scales of the Adaptive Stress Index (ASI), and a measure of resilience (the Connor-Davidson Resilience Scale [CDRS]). Compared to CBT, an intention-to-treat analysis (n = 331) at 6-week posttreatment follow-up demonstrated greater reductions in the IAT arm for all common mental disorder (CMD) symptoms and ASI domains except for ASI-3 (injustice), as well as increases in the resilience scores. Adjusted average treatment effects assessing the differences in posttreatment scores between IAT and CBT (with baseline scores as covariates) were -0.08 (95% CI: -0.14 to -0.02, p = 0.012) for PTSD, -0.07 (95% CI: -0.14 to -0.01) for CPTSD, -0.07 for MDD (95% CI: -0.13 to -0.01, p = 0.025), 0.16 for CDRS (95% CI: 0.06-0.026, p ≤ 0.001), -0.12 (95% CI: -0.20 to -0.03, p ≤ 0.001) for ASI-1 (safety/security), -0.10 for ASI-2 (traumatic losses; 95% CI: -0.18 to -0.02, p = 0.02), -0.03 for ASI-3 (injustice; (95% CI: -0.11 to 0.06, p = 0.513), -0.12 for ASI-4 (role/identity disruptions; 95% CI: -0.21 to -0.04, p ≤ 0.001), and -0.18 for ASI-5 (existential meaning; 95% CI: -0.19 to -0.05, p ≤ 0.001). Compared to CBT, the IAT group had larger effect sizes for all indices (except for resilience) including PTSD (IAT, d = 0.93 versus CBT, d = 0.87), CPTSD (d = 1.27 versus d = 1.02), MDD (d = 1.4 versus d = 1.11), ASI-1 (d = 1.1 versus d = 0.85), ASI-2 (d = 0.81 versus d = 0.66), ASI-3 (d = 0.49 versus d = 0.42), ASI-4 (d = 0.86 versus d = 0.67), and ASI-5 (d = 0.72 versus d = 0.53). No adverse events were recorded for either therapy. Limitations include a possible allegiance effect (the authors inadvertently conveying disproportionate enthusiasm for IAT in training and supervision), cross-over effects (counsellors applying elements of one therapy in delivering the other), and the brief period of follow-up. CONCLUSIONS: Compared to CBT, IAT showed superiority in improving mental health symptoms and adaptative stress from baseline to 6-week posttreatment. The differences in scores between IAT and CBT were modest and future studies conducted by independent research teams need to confirm the findings. TRIAL REGISTRATION: The study is registered under Australian New Zealand Clinical Trials Registry (ANZCTR) (http://www.anzctr.org.au/). The trial registration number is: ACTRN12617001452381.
引用
- Tay AK, Mung HK, Miah MAA, et al. An Integrative Adapt Therapy for common mental health symptoms and adaptive stress amongst Rohingya, Chin, and Kachin refugees living in Malaysia: A randomized controlled trial. PLoS Med. 2020. PMID: 32231364. doi:10.1371/journal.pmed.1003073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。